Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Partners with Hoffmann-La Roche, Others on MDx Platform Using FFPE

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A team of industry players and clinical researchers today announced a collaboration to develop a platform for using frozen formalin paraffin-embedded tissue for molecular diagnostics.

The project, which has a budget of $5 million — half of which will be funded by the Danish National Advanced Technology Foundation — involves CLC bio, Aros Applied Biotechnology, F. Hoffman-La Roche, and Aarhus University Hospital – the Institute of Pathology and the Research Unit for Molecular Medicine.

The goal is to develop a complete platform for selecting FFPE samples, choosing sequencing technology, and then assembling and analyzing the high-throughput sequencing data, the partners said in a statement.

In addition to the development of molecular diagnostics, the platform will be used to reanalyze pre-clinical trials for drugs that have failed despite achieving relatively high rates of positive responses.

According to the partners, getting high-quality fresh samples is a challenge to both academia and pharmaceutical firms. The proposed platform will provide researchers access to "vastly more samples" than can be collected in traditional fresh tissue biobanks. The samples can be linked to patient data through healthcare, disease, and population registries, "providing unique opportunities to boost research in disease mechanisms and rescue drugs from failure," they said.

"Having access to high-throughput genomic analyses of the vast number of existing archive FFPE samples will be an invaluable contribution" to being able to compare diseased tissue to a broad range of control samples, thereby facilitating personalized medicine, said Stephen Hamilton Dutoit, a professor at the Institute of Pathology at Aarhus University Hospital.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.